A rare genetic condition, Spinal Muscular Atrophy (SMA) affects one in 7,000 people in India. It mostly affects children and ...

Bone Density Loss: Prolonged exposure to microgravity can also lead to decreased bone density, increasing the risk of fractures. Research indicates that astronauts can lose around 1% of their bone ...

The realm of outer space has long fascinated humanity, but it also holds significant challenges, especially concerning human health. Recently, the return of two astronauts who spent nine months in ...

A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

Researchers at Penn Vet and the University of Padova identified a novel variant connected to progressive retinal atrophy ...

Frederic L.W.V.J. Schaper, MD, PhD, director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at Brigham and Women's Hospital and an instructor of neurology at Harvard Medical ...

Activating a protein called potassium channel Kv2.1 may help improve motor function in SMA, making it a potential SMA ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

Apitegromab is an investigational treatment aimed at improving motor function for people living with spinal muscular atrophy. Scholar Rock said it has also submitted and received validation for its ...

NASA astronaut Sunita Williams recently returned from space and is dealing with several health concerns. After spending ...

Generalized epilepsy has traditionally been considered a seizure of the "'whole brain.'" However, new research has challenged ...

A higher dose of Spinraza may be more effective than the currently approved dosing schedule for maintaining motor function in ...